According to a recent LinkedIn post from ABM Respiratory Care, the company plans to participate in the Symposium by the Sea conference in Virginia Beach, Va., from March 18–20. The post highlights live, hands-on demonstrations of its BiWaze airway clearance platform, including the BIWAZE Cough and BIWAZE Clear systems, positioned for use across hospital and home settings.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The LinkedIn post also notes an educational session by Quyen Duong, RRT, on “Understanding Oscillating Lung Expansion (OLE) Therapy,” suggesting a focus on clinician engagement and clinical validation. For investors, the emphasis on real-time demos, dual blower technology, and new clinical studies may indicate efforts to drive adoption, differentiate the BiWaze platform, and potentially support longer-term revenue growth in the respiratory care segment.
The post further points readers to online resources for exploring the BiWaze platform and scheduling demos outside the event, implying a hybrid outreach strategy beyond in-person conferences. If these activities translate into stronger clinician awareness and institutional uptake, ABM Respiratory Care could enhance its competitive position in airway clearance and lung health technologies, though commercial impact will depend on conversion of interest into contracts and sustained utilization.